Medexus Pharmaceuticals Inc (OTCPK:MEDXF)
$ 1.509 0.124 (8.95%) Market Cap: 37.62 Mil Enterprise Value: 72.91 Mil PE Ratio: 30.18 PB Ratio: 1.17 GF Score: 69/100

Medexus Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference Transcript

Apr 25, 2023 / 01:30PM GMT
Release Date Price: $1.02 (+2.00%)
James Tran
Bloom Burton & Co. - Moderator

Hello, good morning, everyone. Welcome. I think we're going to have people trickling in as the TSX actually opens, and people file in from there. But I think we should start with this session.

Good morning, everyone, and welcome to the 2023 Bloom Burton & Co. healthcare investor conference. You're joining us in Hall B for company presentations. And we'll have five presentations this morning.

First, this morning -- the first presentation will be given by Medexus Pharma. Joining us is Ken d'Entremont, the CEO. He'll be giving a 25-minute -- or 20 to 25-minute presentation, and it will be followed by five minutes of Q&A. If you do have a question, please hold it until the end. We'll come around with a mic so that everyone can hear the question.

So I'd like to welcome Ken to the stage. Ken, the floor is yours. Thank you.

Ken d;Entremont
Medexus Pharmaceuticals, Inc. - CEO & Director

' -

Thank you, James. I want to thank Bloom Burton for the wonderful opportunity

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot